US food and drug regulator had inspected the company’s two facilities, one at Vizag in AP and another at Jeedi-metla, Hyderabad.
Representational image
Hyderabad: Drug maker Granules India on Monday said that US FDA has made three observations on its facility on the outskirts of Hyderabad.
“There are no observations for Vizag facility and three observations for Jeedimetla facility. The company will respond to the observations in 15 business days,” the company said in a statement. US food and drug regulator had inspected the company’s two facilities — one at Vizag in AP and another at Jeedi-metla, Hyderabad in Telangana.
Download the all new Deccan Chronicle app for Android and iOS to stay up-to-date with latest headlines and news stories in politics, entertainment, sports, technology, business and much more from India and around the world.
( Source : deccan chronicle )
Next Story
